IL96654A - Sutral derivatives containing hydroxybenzyl and sulfur-converted, and pharmaceutical preparations containing them - Google Patents

Sutral derivatives containing hydroxybenzyl and sulfur-converted, and pharmaceutical preparations containing them

Info

Publication number
IL96654A
IL96654A IL9665490A IL9665490A IL96654A IL 96654 A IL96654 A IL 96654A IL 9665490 A IL9665490 A IL 9665490A IL 9665490 A IL9665490 A IL 9665490A IL 96654 A IL96654 A IL 96654A
Authority
IL
Israel
Prior art keywords
compound
alkyl
formula
hydrogen
inclusive
Prior art date
Application number
IL9665490A
Other languages
English (en)
Hebrew (he)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority to IL10896290A priority Critical patent/IL108962A/en
Publication of IL96654A publication Critical patent/IL96654A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/36—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Eye Examination Apparatus (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Surgical Instruments (AREA)
  • Nonmetallic Welding Materials (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL9665490A 1989-12-21 1990-12-13 Sutral derivatives containing hydroxybenzyl and sulfur-converted, and pharmaceutical preparations containing them IL96654A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL10896290A IL108962A (en) 1989-12-21 1990-12-13 Use of hydrocarbon-containing sulfur-containing heterocyclic histories, process for their preparation and pharmaceutical preparations containing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45420389A 1989-12-21 1989-12-21

Publications (1)

Publication Number Publication Date
IL96654A true IL96654A (en) 1995-06-29

Family

ID=23803709

Family Applications (3)

Application Number Title Priority Date Filing Date
IL10896290A IL108962A (en) 1989-12-21 1990-12-13 Use of hydrocarbon-containing sulfur-containing heterocyclic histories, process for their preparation and pharmaceutical preparations containing them
IL9665490A IL96654A (en) 1989-12-21 1990-12-13 Sutral derivatives containing hydroxybenzyl and sulfur-converted, and pharmaceutical preparations containing them
IL10896294A IL108962A0 (en) 1989-12-21 1994-03-14 Use of hydroxybenzyl substituted sulfur containing heterocyclic derivatives, a process for their preparation and pharmaceutical compositions containing them

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL10896290A IL108962A (en) 1989-12-21 1990-12-13 Use of hydrocarbon-containing sulfur-containing heterocyclic histories, process for their preparation and pharmaceutical preparations containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL10896294A IL108962A0 (en) 1989-12-21 1994-03-14 Use of hydroxybenzyl substituted sulfur containing heterocyclic derivatives, a process for their preparation and pharmaceutical compositions containing them

Country Status (22)

Country Link
EP (1) EP0434394B1 (ja)
JP (1) JP3036853B2 (ja)
KR (1) KR0176243B1 (ja)
CN (1) CN1029846C (ja)
AT (1) ATE169294T1 (ja)
AU (1) AU639734B2 (ja)
CA (1) CA2032330C (ja)
CY (1) CY2100B1 (ja)
DE (1) DE69032537T2 (ja)
DK (1) DK0434394T3 (ja)
ES (1) ES2121748T3 (ja)
FI (2) FI104251B1 (ja)
HU (1) HU216732B (ja)
IE (1) IE904633A1 (ja)
IL (3) IL108962A (ja)
MX (1) MX23803A (ja)
NO (1) NO300458B1 (ja)
NZ (1) NZ236472A (ja)
PT (1) PT96198B (ja)
RU (2) RU2036915C1 (ja)
YU (1) YU240690A (ja)
ZA (1) ZA9010041B (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU87339A1 (fr) * 1988-09-20 1990-04-06 Oreal Nouveaux derives de benzylidene-cyclanones,leur procede de preparation,leur utilisation en tant qu'agents anti-oxydants et comme filtres solaires,compositions cosmetiques et pharmaceutiques les contenant
US5143928A (en) * 1990-03-27 1992-09-01 Warner-Lambert Company 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
ZA936492B (en) * 1992-09-10 1995-03-02 Lilly Co Eli Compounds useful as hypoglycemic agents and for treating Alzheimer's disease.
DK0595546T3 (da) * 1992-10-28 1996-04-15 Shionogi & Co Benzylidenderivater
US6251928B1 (en) 1994-03-16 2001-06-26 Eli Lilly And Company Treatment of alzheimer's disease employing inhibitors of cathepsin D
US5563277A (en) * 1994-12-21 1996-10-08 Eli Lilly And Company Process for preparing benzyl-substituted rhodanine derivatives
EP0761657B1 (en) * 1995-09-07 2000-05-24 Eli Lilly And Company Process for preparing benzyl-substituted rhodanine derivatives
IN182320B (ja) * 1995-09-07 1999-03-20 Lilly Co Eli
EP0779282A1 (en) * 1995-12-14 1997-06-18 Eli Lilly And Company Thiomorpholinone compounds for treating multiple sclerosis
US5981523A (en) * 1996-02-05 1999-11-09 Eli Lilly And Company Compounds and methods for treating multiple sclerosis
US6063799A (en) * 1996-09-03 2000-05-16 Eli Lilly And Company Alternate crystal form of Tazofelone
US6005142A (en) 1996-09-03 1999-12-21 Eli Lilly And Company Process for preparing benzyl-substituted rhodanine derivatives
WO2000018746A1 (en) * 1998-09-30 2000-04-06 Roche Diagnostics Gmbh Thiazolidine derivatives for the treatment and prevention of metabolic bone disorders
EP1117655A1 (en) 1998-09-30 2001-07-25 Angelika Esswein Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders
AU6330999A (en) * 1998-09-30 2000-04-17 Roche Diagnostics Gmbh Rhodanine derivatives for the treatment and prevention of metabolic bone disorders
US7235573B2 (en) 2002-09-30 2007-06-26 The Regents Of The University Of California Methods of treating secretory diarrhea using cystic fibrosis transmembrane conductance regulator protein inhibitors
NZ538809A (en) * 2002-09-30 2008-06-30 Univ California Thiazolidinone cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof
AU2002953533A0 (en) 2002-12-24 2003-01-16 Arthron Limited Fc receptor modulating compounds and compositions
JP5778755B2 (ja) * 2010-04-15 2015-09-16 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ ヒドロキノンの製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1285572C (en) * 1985-08-09 1991-07-02 Jill Ann Panetta Di-t-butylphenol compounds
IE62214B1 (en) * 1988-05-25 1995-01-11 Warner Lambert Co Arylmethylenyl derivatives of thiazolidinones, imidazolidinones and oxazolidinones useful as antiallergy agents and antiinflammatory agents
DE69027472T2 (de) * 1989-04-07 1996-12-05 Lilly Co Eli Arylsubstituierte Rhodaninderivate

Also Published As

Publication number Publication date
FI104251B (fi) 1999-12-15
JP3036853B2 (ja) 2000-04-24
AU639734B2 (en) 1993-08-05
DK0434394T3 (da) 1998-12-14
ES2121748T3 (es) 1998-12-16
NZ236472A (en) 1993-03-26
JPH04279573A (ja) 1992-10-05
IL108962A0 (en) 1994-06-24
RU2050355C1 (ru) 1995-12-20
CA2032330C (en) 2001-05-08
CN1029846C (zh) 1995-09-27
PT96198B (pt) 1998-05-29
ATE169294T1 (de) 1998-08-15
PT96198A (pt) 1991-09-30
EP0434394B1 (en) 1998-08-05
YU240690A (sh) 1992-12-21
NO300458B1 (no) 1997-06-02
FI906273A0 (fi) 1990-12-19
CA2032330A1 (en) 1991-06-22
DE69032537D1 (de) 1998-09-10
HU908368D0 (en) 1991-07-29
FI906273A (fi) 1991-06-22
MX23803A (es) 1994-02-28
ZA9010041B (en) 1992-08-26
RU2036915C1 (ru) 1995-06-09
NO905478L (no) 1991-06-24
IE904633A1 (en) 1991-07-17
AU6826690A (en) 1991-06-27
IL108962A (en) 1996-12-05
NO905478D0 (no) 1990-12-19
EP0434394A3 (en) 1992-01-08
CN1052668A (zh) 1991-07-03
EP0434394A2 (en) 1991-06-26
DE69032537T2 (de) 1999-01-21
FI19991698A (fi) 1999-08-10
KR0176243B1 (ko) 1999-03-20
CY2100B1 (en) 2002-04-05
HUT59915A (en) 1992-07-28
HU216732B (hu) 1999-08-30
FI104251B1 (fi) 1999-12-15
KR910011812A (ko) 1991-08-07

Similar Documents

Publication Publication Date Title
EP0434394B1 (en) Compounds for treating inflammatory bowel disease
US5387690A (en) Method of treating inflammatory bowel disease
CA1304371C (en) Benzoxazole derivatives and preparation thereof
KR20030097596A (ko) 치환된 티아졸리딘디온 유도체
KR20000016412A (ko) 신규한 치환 2,4-티아졸리디네디온 유도체, 이의제조 방법 및이를 함유하는 약제학적 조성물
AU629322B2 (en) Aryl-substituted rhodanine derivatives
US5158966A (en) Method of treating type i diabetes
US5356917A (en) Aryl-substituted rhodanine derivatives
KR960012206B1 (ko) 티아졸리딘-2,4-디온 유도체 및 이의 염, 이의 제조방법 및 이의 용도
EP0283036B1 (en) Benzoxazine derivatives and processes for preparation thereof
US5731336A (en) Method for treating multiple sclerosis
CH633010A5 (fr) Derives de l'isoquinoleine, leur preparation et medicament qui les contient.
US4845231A (en) Tetrazoles and their use as hypoglycemic agents
US5563277A (en) Process for preparing benzyl-substituted rhodanine derivatives
US5468761A (en) 4-methyl-5-substituted-1,3-oxazoles having anti-inflammatory activity
US5691367A (en) Aryl-substituted rhodanine derivatives
JPH0469385A (ja) 新規イミダゾリン誘導体

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees